Investors/Media

June 6, 2024
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 6, 2024-- Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the
May 1, 2024
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 1, 2024-- Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier
Displaying 1 - 10 of 15